Melissa Paoloni

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Genomics 10:625. 2009
  2. doi request reprint Translation of new cancer treatments from pet dogs to humans
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 2144, Bethesda, Maryland 20892, USA
    Nat Rev Cancer 8:147-56. 2008
  3. doi request reprint The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Vet J 185:88-9. 2010
  4. pmc A compendium of canine normal tissue gene expression
    Joseph Briggs
    Tumor and Metastasis Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 6:e17107. 2011
  5. pmc Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
    PLoS ONE 10:e0129954. 2015
  6. pmc Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
    PLoS ONE 9:e90028. 2014

Collaborators

Detail Information

Publications6

  1. pmc Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    BMC Genomics 10:625. 2009
    ....
  2. doi request reprint Translation of new cancer treatments from pet dogs to humans
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, Room 2144, Bethesda, Maryland 20892, USA
    Nat Rev Cancer 8:147-56. 2008
    ....
  3. doi request reprint The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Vet J 185:88-9. 2010
    ....
  4. pmc A compendium of canine normal tissue gene expression
    Joseph Briggs
    Tumor and Metastasis Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 6:e17107. 2011
    ..Accordingly, we now present the first genome-wide, canine normal tissue gene expression compendium with corresponding human cross-species analysis...
  5. pmc Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
    PLoS ONE 10:e0129954. 2015
    ..Specifically this study sought to evaluate the safety, serum pharmacokinetics, anti-tumor activity, and immune modulation of NHS-IL12 in dogs with naturally occurring cancers...
  6. pmc Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials
    Melissa Paoloni
    Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America
    PLoS ONE 9:e90028. 2014
    ..In order to realize this opportunity, it is now necessary to demonstrate the feasibility of conducting molecularly-guided analysis of tumors from dogs with naturally occurring cancer in a clinically relevant setting...